TI  - The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
AU  - Amin, O.A.
AU  - Alaarag, A.F.
SO  - The Anatolian Journal of Cardiology 2021;25:163-169.
DO  - 10.14744/AnatolJCardiol.2020.39267